A clinical human trial of coronavirus vaccine began on March 17, 2020. The United States National Institutes of Health (NIH) and a pharmaceutical company Moderna have developed a shot to test on participants. They will get different doses of shots to ensure that “the vaccines show no worrisome side effects,” AP News reported. Another goal of this clinical trial is to set the stage for larger tests.
The participants are 45 individuals from 18 to 55 years of age, and have tested negative to coronavirus. They won’t get the virus from clinical shots, because they don’t have the virus in their bodies to begin with.
NIH and Moderna are not the only ones looking for a coronavirus vaccine. Research groups around the world are testing the vaccines as the number of positive cases grows. Interestingly, they’re working on different types of vaccines. While some search for shots involving new technologies, others search for temporary vaccines to help the world combat the virus until a more permanent cure is in place.
Public health officials predict it will take a year to 18 months to ensure the validity of any coronavirus vaccine. In addition, it’s going to take additional time to mass produce and roll out the vaccine onto the market.